Noninvasive identification of ATTRwt cardiac amyloid: The re-emergence of nuclear cardiology

American Journal of Medicine

Volumn 128, Issue 12, 2015, Pages 1275-1280

  Maurer, Mathew S ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

Aging; Cardiac amyloid; Senile cardiac amyloid; Technetium pyrophosphate

Indexed keywords

PREALBUMIN; PYROPHOSPHATE; PYROPHOSPHATE TECHNETIUM TC 99M;

BONE SCINTISCANNING; CARDIOVASCULAR MAGNETIC RESONANCE; ELECTROCARDIOGRAM; HEART AMYLOIDOSIS; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE BIOPSY; HUMAN; PRIORITY JOURNAL; REVIEW; AMYLOIDOSIS; DIAGNOSTIC IMAGING; HEART; HEART DISEASES; SCINTISCANNING;

AMYLOIDOSIS; HEART; HEART DISEASES; HEART FAILURE; HUMANS; RADIONUCLIDE IMAGING; TECHNETIUM TC 99M PYROPHOSPHATE;

EID: 84947864652     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.05.039     Document Type: Review

References (61)

1. L.W. Miller, and E.D. Missov Epidemiology of heart failure Cardiol Clin 19 2001 547 555
2. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
3. B.M. Massie, P.E. Carson, J.J. McMurray, and et al. Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
4. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, and J. Taylor The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
5. S. Yusuf, M.A. Pfeffer, K. Swedberg, and et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
6. M.M. Redfield, H.H. Chen, B.A. Borlaug, and et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 2013 1268 1277
7. B. Pitt, M.A. Pfeffer, S.F. Assmann, and et al. Spironolactone for heart failure with preserved ejection fraction N Engl J Med 370 2014 1383 1392
8. L. van Heerebeek, A. Borbely, H.W. Niessen, and et al. Myocardial structure and function differ in systolic and diastolic heart failure Circulation 113 2006 1966 1973
9. A. Borbely, J. van der Velden, Z. Papp, and et al. Cardiomyocyte stiffness in diastolic heart failure Circulation 111 2005 774 781
10. J.G. Bronzwaer, and W.J. Paulus Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction? Prog Cardiovasc Dis 47 2005 276 284
11. L. van Heerebeek, N. Hamdani, M.L. Handoko, and et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension Circulation 117 2008 43 51
12. D. Lebeche, A.J. Davidoff, and R.J. Hajjar Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy Nat Clin Pract Cardiovasc Med 5 2008 715 724
13. M.R. Zile, K. Richardson, M.K. Cowles, and et al. Constitutive properties of adult mammalian cardiac muscle cells Circulation 98 1998 567 579
14. H.L. Granzier, and T.C. Irving Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments Biophys J 68 1995 1027 1044
15. M.M. LeWinter, and H. Granzier Cardiac titin: a multifunctional giant Circulation 121 2010 2137 2145
16. A. Borbely, I. Falcao-Pires, L. van Heerebeek, and et al. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium Circ Res 104 2009 780 786
17. A. Gonzalez, B. Lopez, R. Querejeta, E. Zubillaga, T. Echeverria, and J. Diez Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction Hypertension 55 2010 1418 1424
18. A.D. Bradshaw, C.F. Baicu, T.J. Rentz, and et al. Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing Circulation 119 2009 269 280
19. A. Borbely, Z. Papp, I. Edes, and W.J. Paulus Molecular determinants of heart failure with normal left ventricular ejection fraction Pharmacol Rep 61 2009 139 145
20. S.H. Ahmed, L.L. Clark, W.R. Pennington, and et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease Circulation 113 2006 2089 2096
21. T. Bhuiyan, S. Helmke, A.R. Patel, and et al. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS) Circ Heart Fail 4 2 2011 121 128
22. S.J. Lavine Genesis of the restrictive filling pattern: pericardial constraint or myocardial restraint J Am Soc Echocardiogr 17 2004 152 160
23. R.E. Petre, M.P. Quaile, K. Wendt, and et al. Regionally heterogeneous tissue mechanics in cardiac amyloidosis Amyloid 12 2005 246 250
24. K. Dharmarajan, and M.S. Maurer Transthyretin cardiac amyloidoses in older North Americans J Am Geriatr Soc 60 2012 765 774
25. N.B. Cyrille, J. Goldsmith, J. Alvarez, and M.S. Maurer Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis Am J Cardiol 114 2014 1089 1093
26. C. Rapezzi, C.C. Quarta, P.L. Guidalotti, and et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis JACC Cardiovasc Imaging 4 2011 659 670
27. R. Bauer, N. Dikow, A. Brauer, and et al. The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy Amyloid 21 2014 267 275
28. W.A. Aljaroudi, M.Y. Desai, W.H. Tang, D. Phelan, M.D. Cerqueira, and W.A. Jaber Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques J Nucl Cardiol 21 2014 271 283
29. A.W. Glaudemans, R.W. van Rheenen, M.P. van den Berg, and et al. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis Amyloid 21 2014 35 44
30. C.C. Quarta, S.D. Solomon, I. Uraizee, and et al. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis Circulation 129 2014 1840 1849
31. F.L. Ruberg, E. Appelbaum, R. Davidoff, and et al. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis Am J Cardiol 103 2009 544 549
32. H. Vogelsberg, H. Mahrholdt, C.C. Deluigi, and et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy J Am Coll Cardiol 51 2008 1022 1030
33. E. Perugini, C. Rapezzi, T. Piva, and et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance Heart 92 2006 343 349
34. A.M. Maceira, J. Joshi, S.K. Prasad, and et al. Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193
35. R.I. vanden Driesen, R.E. Slaughter, and W.E. Strugnell MR findings in cardiac amyloidosis AJR Am J Roentgenol 186 2006 1682 1685
36. R. Wassmuth, H. Abdel-Aty, S. Bohl, and J. Schulz-Menger Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis Eur Radiol 21 2011 1643 1650
37. A. Castano, B.M. Drachman, D. Judge, and M.S. Maurer Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs Heart Fail Rev 20 2 2015 163 178
38. T. Coelho, M.S. Maurer, and O.B. Suhr THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis Curr Med Res Opin 29 2013 63 76
39. T. Damy, D. Mohty, J.F. Deux, and et al. Senile systemic amyloidosis: definition, diagnosis, why thinking about? [French] Presse Med 42 2013 1003 1014
40. D.R. Jacobson, P.D. Gorevic, and J.N. Buxbaum A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology Am J Hum Genet 47 1990 127 136
41. D.R. Jacobson, R.D. Pastore, R. Yaghoubian, and et al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans N Engl J Med 336 1997 466 473
42. R.A. Pages, J. Robbins, and H. Edelhoch Binding of thyroxine and thyroxine analogs to human serum prealbumin Biochemistry 12 1973 2773 2779
43. M.J. Saraiva Transthyretin mutations in hyperthyroxinemia and amyloid diseases Hum Mutat 17 2001 493 503
44. A. Quintas, D.C. Vaz, I. Cardoso, M.J. Saraiva, and R.M. Brito Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants J Biol Chem 276 29 2001 27207 27213
45. P. Hammarstrom, X. Jiang, A.R. Hurshman, E.T. Powers, and J.W. Kelly Sequence-dependent denaturation energetics: a major determinant in amyloid disease diversity Proc Natl Acad Sci U S A 99 suppl 4 2002 16427 16432
46. P.P. Costa, A.S. Figueira, and F.R. Bravo Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy Proc Natl Acad Sci U S A 75 1978 4499 4503
47. M. Tanskanen, T. Peuralinna, T. Polvikoski, and et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study Ann Med 40 2008 232 239
48. S.A. Mirzoyev, W.D. Edwards, S.F. Mohammed, and et al. Cardiac amyloid deposition is common in elderly patients with heart failure and preserved ejection fraction Circulation 122 2010 A17926
49. S.S. Wadhwa, and R. Nour Tc-99m HDP uptake in cardiac amyloidosis Clin Nucl Med 24 1999 156 158
50. D.F. Hutt, A.M. Quigley, J. Page, and et al. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis Eur Heart J Cardiovasc Imaging 15 11 2014 1289 1298
51. S. Longhi, P.L. Guidalotti, C.C. Quarta, and et al. Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy JACC Cardiovasc Imaging 7 5 2014 531 532
52. A.V. Kristen, K. Scherer, S. Buss, and et al. Noninvasive risk stratification of patients with transthyretin amyloidosis JACC Cardiovasc Imaging 7 5 2014 502 510
53. S. Sachchithanantham, and A.D. Wechalekar Imaging in systemic amyloidosis Br Med Bull 107 2013 41 56
54. A.V. Kristen, S. Haufe, S.O. Schonland, and et al. Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis Int J Cardiol 164 2013 179 184
55. C. Rapezzi, P. Guidalotti, F. Salvi, L. Riva, and E. Perugini Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis J Am Coll Cardiol 51 15 2008 1509 1510 author reply 1510
56. S. Bokhari, A. Castano, T. Pozniakoff, S. Deslisle, F. Latif, and M.S. Maurer (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses Circ Cardiovasc Imaging 6 2013 195 201
57. A. Castano, S. Bokhari, T.H. Brannagan 3rd, J. Wynn, and M.S. Maurer Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review Amyloid 19 2012 41 46
58. M. Hongo, J. Hirayama, T. Fujii, and et al. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy Am Heart J 113 1987 654 662
59. T.A. Wizenberg, J. Muz, Y.H. Sohn, W. Samlowski, and A.M. Weissler Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis Am Heart J 103 1982 468 473
60. S. Bokhari, R. Shahzad, A. Castano, and M.S. Maurer Nuclear imaging modalities for cardiac amyloidosis J Nucl Cardiol 21 2014 175 184
61. D. Mohty, T. Damy, P. Cosnay, and et al. Cardiac amyloidosis: updates in diagnosis and management Arch Cardiovasc Dis 106 2013 528 540